3. Analyze the PCR products by agarose gel electrophoresis. Cut out a band of the expected size from the gel, and recover a DNA fragment using the PureLink Quick Gel Extraction Kit. If the PCR product appears as a clean single band and a primer dimer is not detected on the agarose gel, the PCR product may optionally be purified using the PureLink PCR Purification Kit instead of performing gel extraction.
4. Cleave the PCR products with the selected restriction enzymes, and purify the reaction products using the PureLink PCR Purification Kit.
5. Since pAAV-2Aneo and pAAV-2Aneo v2 have different 'frame adjusters', these vectors are processed in different fashions to adjust reading frames. Follow one of the three options below (steps A5a-c) to process the frame adjuster. In any of the three options, the restriction enzymedigested DNA solution should be purified using the PureLink PCR Purification Kit or other methods before self-religation. Self-religation is performed using the Quick Ligation Kit.
a. When pAAV-2Aneo is used and the promoter-trap module is to be incorporated into an intron 7. Spread the transformed competent cells onto an LB plate containing 50 µg/ml of ampicillin.
8. Incubate the cells overnight at 37 °C.
9. Pick several colonies with pipette tips, and culture the cells in 2.5 ml of LB containing 50 µg/ml of ampicillin, overnight at 37 °C.
10. Perform mini-prep using the Mini Plus plasmid DNA extraction system as per manufacturer's instructions.
11. Confirm that the frame adjuster has been truncated as intended by sequencing the recovered plasmids using the BigDye Terminator v3.1 Cycle Sequencing Kit and a sequencing primer (e.g., Neo R -Rev #1, a primer complementary to the Neo R gene).
12. To clone one of the PCR-amplified homology arms, cleave the plasmid verified in step A11 with an appropriate restriction enzyme(s). If required, use alkaline phosphatase to prevent selfreligation of the plasmid. Purify the linearized plasmid using the PureLink PCR Purification Kit.
13. Ligate the linearized plasmid with the PCR-amplified homology arm that was trimmed and purified in step A4.
14. Repeat steps A6-A10 with the ligation product.
15. Check for the successful insertion of the homology arm by digesting the resultant plasmids (mini-preps) with an appropriate restriction enzyme(s) and resolving the DNA fragments on an agarose gel. 17. To clone another homology arm, cleave the plasmid from step A16 using an appropriate restriction enzyme(s) with or without alkaline phosphatase, and purify the linearized plasmid using the PureLink PCR purification kit. Then, repeat steps A13-A16. 2. On the following day, aspirate the medium, and add 5 ml of Opti-MEM I reduced-serum medium.
Note: Washing the cells prior to the addition of Opti-MEM I reduced-serum medium is optional; however, proceed with caution when washing, as the HEK293(T) cells are loosely adherent
to the culture dish.
3. Pipette the following plasmids into 1.5 ml of Opti-MEM I reduced-serum medium and gently mix: 2. Centrifuge the 15-ml tube at 400 x g (1,500 rpm) for 5 min at room temperature, and discard the supernatant completely but carefully so as not to remove the cells.
3. Wash the cells with PBS(-), centrifuge the 15-ml tube at 400 x g for 5 min, and discard the PBS(-) completely but carefully so as not to remove the cells.
4. Resuspend the cell pellet in 1.0 ml of PBS(-).
Note: If the cell line that will be infected with the AAV vector in preparation is already known, the cell pellet in step C 4 can be resuspended in a medium appropriate for that cell line instead of PBS(-).
5. Prepare chilled methanol by pouring methanol onto dry ice. Set the temperature of a water bath to 37 °C.
Note: Wear safety glasses to protect eyes when chilled methanol is being prepared and used.
6. Dip the 15-ml tube into chilled methanol until the cell suspension is completely frozen.
7. Transfer the 15-ml tube to the 37 °C water bath, and incubate until the cell suspension is completely thawed.
8. Repeat steps C6 and C7 thrice (four cycles in total).
9. Centrifuge the 15-ml tube at 400 x g for 5 min at room temperature, and transfer the supernatant to a 1.5-ml or 2-ml cryovial.
10. Use the resulting AAV stock immediately for titering or cell infection, or store it at -80 °C until use.
Avoid extra freeze-thaw cycles.
Note: The AAV solution prepared as above can be purified using density gradient centrifugation or affinity columns prior to its use for infection, and these procedures have been described in published protocols (Khan et al., 2011; Howes and Schofield, 2015) . 8. Perform qPCR amplification using StepOnePlus with the experimental conditions below. The post-amplification melt curve analysis includes 1 min at 95 °C and 1 min at 55 °C followed by a slow temperature increment to 95 °C.
Step 1: 95 °C 2 min
Step of an AAV-based targeting vector by comparing its amplification profile with that of serially diluted standard samples. Note that the AAV solution used for qPCR was diluted 20-fold when it was treated with DNase I in step D3. An example of standard curves generated in qPCRs is shown in Figure 8 . 3. The day after cell propagation, thaw the AAV stock stored at -80 °C in a 37 °C water bath.
4. Aspirate the medium from the 75-cm 2 flask, and pour (5-x) ml of growth medium onto the cells, where x (ml) represents a predetermined volume of the AAV stock.
Note: The volume of the AAV stock used is determined by the multiplicity of infection (MOI) that is used to infect the cells. We generally infect cells with AAV-based targeting vectors
at a MOI of 1 x 10 4 Konishi et al., 2012; Damdindorj et al., 2014; Karnan et al., 2016) ; however, a range of MOI can be applied depending on the experiment (Russell and Hirata, 1998; Hirata and Russell, 2000; Miller et al., 2003; Porteus et al., 2003) . 2. Swirl the flask and examine it under a microscope to confirm that the cells are dissociated.
Then, add the appropriate volume of growth medium to the flask, pipette to further dissociate the cells, and transfer the cell suspension into a 15-ml (or 50-ml) conical tube.
3. Centrifuge the cells at 400 x g for 5 min, discard the supernatant, and resuspend the cells in 14 ml of growth medium containing the appropriate concentration of G418.
Note: In this protocol, G418 selection is initiated when cells are seeded into 96-well tissue culture plates as this expedites the selection of cells. However, if the cell line being infected is sensitive to sparse seeding, it is advisable to begin G418 selection 1-3 days after seeding when the cells have attached to the wells. This may increase the number of colonies obtained following G418 selection.
4. Distribute the cells into seven 96-well plates. First, pour 6 ml of cell suspension to a sterilized pipetting reservoir, and then add 52 ml of growth medium containing G418.
5. Mix the cell suspension in the reservoir by pipetting, and inoculate the cells in three 96-well plates (200 μl/well) using a 12-channel pipettor.
6. Pour 4 ml of cell suspension to the reservoir, and add 35 ml of growth medium containing G418.
7. Mix the cell suspension in the reservoir by pipetting, and inoculate the cells in two 96-well plates (200 μl/well) using a 12-channel pipettor.
8. Repeat steps F6 and F7 using the remaining (4 ml) cell suspension.
9. Place the 96-well plates in the CO 2 incubator, and maintain the cells until completion of G418 selection and detection of colonies by microscopy (usually 7-14 days after seeding).
Note: If colonies in the 96-well plates are not clearly visible because of dying cells or dead cells
floating in the medium, the visibility can be improved by changing the medium.
10. Mark wells containing G418-resistant colonies with a permanent marker. Wells that apparently contain multiple colonies should be marked with a different color.
11. Incubate the 96-well plates in the CO 2 incubator for another 7-14 days until cells in the marked wells reach an average of 60-80% confluence.
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12.
Transfer approximately half of the trypsinized cells from each well into a 1.5-ml tube.
13. Add growth medium to the 24-well plates up to 1.5 ml/well, and place the plates back in the CO 2 incubator.
14. Extract genomic DNA from the samples in step G12 using the PureLink Genomic DNA Mini Kit, perform a second screening PCR using KOD FX Neo and the same primer pair as in step Distilled water to 2 L b. Then, 50 ml of 10x PBS(-) is diluted with 450 ml of distilled water in a 500-ml bottle and sterilized by autoclave.
